News Focus
News Focus
Post# of 257433
Next 10
Followers 843
Posts 122881
Boards Moderated 9
Alias Born 09/05/2002

Re: DewDiligence post# 247756

Friday, 03/28/2025 5:16:58 PM

Friday, March 28, 2025 5:16:58 PM

Post# of 257433
VRTX discontinues VX-264 T1D treatment due to low efficacy; VX-880 remains and has been renamed, Zimislecel:

https://www.businesswire.com/news/home/20250328622122/en/Vertex-Announces-Program-Updates-for-Type-1-Diabetes-Portfolio

See #msg-172224254 for background info.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today